The Middle EAST Aripiprazole Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.8%. This growth trajectory reflects a significant increase in the demand for Aripiprazole, a medication primarily used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder. The rising prevalence of mental health...